This has been quite a year, since October we’ve watched global markets falter, a new president get elected and sweeping healthcare reform is being debated on the floors of congress. All this is impacting the pharmaceutical industry and companies are responding by aggressively reducing costs and how to get better results from all of their outsourced clinical research. We know you’re feeling the pressure rise as the volume of outsourced work continues to increase. In order to design a process that will save time in the long run it is important to have a firm grounding in the fundamentals.
For 2009 Fundamentals of Clinical Outsourcing has been updated with timely topics, in-depth roundtable discussions and increased networking opportunities to create a highly focused learning opportunity that will help you better manage your outsourcing partners and expedite clinical trials.
New for 2009!
• Keynote presentation from Ken Getz, Senior Research Fellow from the Tufts Center for the Study of Drug Development on tracking the transition from transaction to portfolio based relationships
• Genzyme and Milennium executives discuss relationship management and The Rules of Engagement
• FDA address from Michael Marcarelli the Director of the Office of Bioresearch Monitoring at CDRH tells participants what the FDA Expects regarding quality oversight of third parties
If you are ready to send a new compound into clinical development and you don’t have the in-house resources to execute the trial or if you are overwhelmed by the choices that need to be made every day to keep your products moving through development, Fundamental of Clinical Outsourcing is your best opportunity to obtain best practices, set your outsourcing strategy and manage successful relationships with proven rules of engagement.
Download the brochure today, and then visit the website to reserve your seat! I look forward to seeing you there.
Web Seminar
Title: Offshoring to Emerging Countries: Navigating Uncertain Waters
Date: Thursday, January 21, 2010
Time: 2:00 PM - 3:00 PM EST
Mention priority code: P1500W2BlogTwitter
Presented by:
Jacquie Mardell
Sr Director Clinical Operations
Metabolex
Sign up for the complimentary webinar here.
Date: Thursday, January 21, 2010
Time: 2:00 PM - 3:00 PM EST
Mention priority code: P1500W2BlogTwitter
Presented by:
Jacquie Mardell
Sr Director Clinical Operations
Metabolex
Sign up for the complimentary webinar here.
Blog Archive
-
▼
2009
(203)
-
►
December
(29)
- Complimentary Web Seminar: Offshoring to Emerging ...
- Happy Holidays from Partnerships in Clinical Trial...
- Complimentary Web Seminar: Offshoring to Emerging ...
- Central Labs Spotlight: Craig Lipset , Pfizer
- Attend Central Labs on us!
- Partnerships keynote speaker Ethan Zohn's cancer i...
- Attend Partnerships in Clinical Trials as a Guest ...
- Central Labs Spotlight: Guy Mascaro and Linda Sull...
- Covance expanding in Asia-Pacific
- How open innovation could reinvigorate the pharmac...
- Would you like to guest blog from Partnerships in ...
- Rules-Based Medicine and Psynova Neurotech Announc...
- Thank you from Partnerships in Clinical Trials Asi...
- Partnerships in Clinical Trials Asia Pacific: Focu...
- Partnerships in Clinical Trials Asia Pacific: Focu...
- Partnerships in Clinical Trials Asia Pacific: Focu...
- Partnerships in Clinical Trials Asia Pacific: Tail...
- Partnerships in Clinical Trials Asia Pacific: The ...
- Partnerships in Clinical Trials Asia Pacific: How ...
- Partnerships in Clinical Trials Asia Pacific: Regi...
- Partnerships in Clinical Trials Asia Pacific: A Da...
- Partnerships in Clinical Trials Asia Pacific: Acce...
- Partnerships in Clinical Trials Asia Pacific: Stra...
- Partnerships in Clinical Trials Asia Pacific: Find...
- Partnerships in Clinical Trials Asia Pacific: Outs...
- Partnerships in Clinical Trials Asia Pacific: Asia...
- Partnerships in Clinical Trials Asia Pacific: New ...
- Partnerships in Clinical Trials Asia Pacific: Welc...
- Central Labs Speaker Profile: Dr. James D Watson
-
►
November
(9)
- Covance Partners with RBM to Extend Biomarker Offe...
- Forced Degradation Brochure Now Available
- Call for Bloggers: Attend Partnerships in Clinical...
- Forced Degradation Forum Brochure Available
- Contract Research Remains Strong According to F&S ...
- A new way to find potential clinical trial partici...
- Partnerships In Clinical Trials Expands Its Global...
- Malaria vaccine trail to begin in east Africa
- Florida Senator wants to see clinical trial expens...
-
►
October
(8)
- PPD Makes Significant Inroad into China Biotech wi...
- Studies may be failing to show adverse effects of ...
- Genzyme begins Phase 3 clinical trial
- Amarin Appoints Medpace as CRO for Two Phase 3 Car...
- Top 5 Clinical Trial Partnering in Asia Pacific Qu...
- Kansas Cancer Center to Join Clinical Trials
- New guidance draft document for REMS
- Adaptive Clinical Trials Benefit Smaller Laborator...
-
▼
July
(20)
- Get Your Clinical Trial Studies Right the First Ti...
- New clinical trial for congestive heart failure
- India: Domestic clinical trials market booms
- Fundamentals of Clinical Outsourcing: Agenda Final...
- New Date Capture and Reporting Service Network has...
- Patients and clinical trials
- ACRO Reports that Clinical Research in Developing...
- India’s CDSCO wants tighter rules for clinical tri...
- 5th Annual Fundamentals of Clinical Outsourcing Ea...
- Education on clinical trials to begin in Qatar
- Clinical Trial Cost & Contract Management Agenda F...
- Swine Flu vaccines approaching time for clinical t...
- PRA International opens office in Korea
- Clinical Research Trials in India
- United Arab Emirates is Set to Rise in Clinical Tr...
- Insourcing Is The New Outsourcing In Biopharma
- New online tool to help with compliance
- Software offers holistic insight into clinical tri...
- How to find the best cost-effective treatments
- Chinese CROs trial express customs clearance
-
►
December
(29)













0 comments:
Post a Comment